Format

Send to

Choose Destination
Skin Pharmacol Physiol. 2018;31(3):147-154. doi: 10.1159/000486688. Epub 2018 Mar 29.

Dermocosmetics for Use in Rosacea: Guideline of the Society for Dermopharmacy.

Author information

1
Irmgardis Pharmacy, Viersen, Germany.
2
Apokindl, Vaterstetten, Germany.
3
bioskin GmbH, Hamburg, Germany.
4
Department of Dermatology and Allergology, Ludwig-Maximilians University, Munich, Germany.

Abstract

Rosacea is a widespread inflammatory skin disease that is chronically recurrent and affects predominately the central parts of the face. Affected individuals typically react to numerous cosmetics with redness, burning, and/or worsening of the complexion. Consequently, there is a high demand for dermocosmetics that do not provoke such reactions and are suitable for use in rosacea. The present guideline of the Society for Dermopharmacy describes the requirements that dermocosmetics for use in rosacea should meet. They include, inter alia, methods to prove the efficacy of and tolerance to these cosmetics, as well as the product documentation that the manufacturer or the distributing company should make available to professionals, like dermatologists and pharmacists, counseling patients with rosacea.

KEYWORDS:

Dermocosmetics; Efficacy; Guideline; Product documentation; Rosacea; Society for Dermopharmacy; Tolerance

PMID:
29597196
DOI:
10.1159/000486688
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center